Queen's pioneers prostate cancer breakthrough
2011-09-19
(Press-News.org) Scientists at Queen's University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.
The treatment, aimed at men with an advanced and aggressive form of prostate cancer which has spread to the bone, is the first of its kind to be developed. It combines traditional chemotherapy treatments with two doses of a radioactive chemical which can target areas of the bone affected by prostate cancer.
Aggressive and advanced prostate cancer is responsible for around 10,000 deaths each year in the UK. Chemotherapy is often used to treat the disease; however, benefits of this treatment are usually short-lived. An ability to combine two different types of drugs against prostate cancer may help improve outcomes including survival for these men.
The results of the first phase of the trial, which are published in the European Journal of Nuclear Medicine and Molecular Imaging, demonstrate that it is safe and feasible to combine multiple injections of the radioactive chemical (Rhenium-186 HEDP) along with standard chemotherapy in men with an aggressive form of prostate cancer.
Dr Joe O'Sullivan, Consultant and Senior Lecturer in Clinical Oncology at the Centre for Cancer Research and Cell Biology at Queen's University, and leader of the study, said: "This is a significant development in the fight against prostate cancer. While this combination treatment still has to go to phase two of trials, to know that this combination is safe and feasible as a treatment is a huge step forward.
"Traditional chemotherapy treatments aren't always effective in treating aggressive and advanced forms of prostate cancer, so we needed to develop a new treatment which will provide better outcomes for patients with this type of cancer. The combination of chemotherapy with the radioactive chemical Rhenium-186 HEDP has the potential to improve outcomes, including survival, for men with this form of cancer.
"The second phase of the trial has already commenced in The Netherlands and will start in the UK within six months. The trial will involve up to 100 patients from Northern Ireland and the Netherlands and it is hoped that results should be known within two years."
INFORMATION:
For media inquiries please contact Claire O'Callaghan on 00 44 (0) 2890975391 / 07814422572 or c.ocallaghan@qub.ac.uk
Notes to Editors:
1. Dr Joe O'Sullivan is available for interview. Interview bids to Claire O'Callaghan on 00 44 (0) 2890975391 / 07814422572 or c.ocallaghan@qub.ac.uk
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-09-19
Current policy pressures on universities to focus on improving their research excellence and to widen participation make it hard for them to engage meaningfully with excluded communities, according to research funded by the Economic and Social Research Council (ESRC). University-community engagement remains marginal to the organisation, funding, management and strategic control of universities. This reduces their benefits for excluded communities.
"Traditionally, universities have regarded excluded communities with an air of detached benevolence," says Dr Paul Benneworth ...
2011-09-19
To cost‑effectively protect the climate, not only an emissions
trading scheme but also financial support for new technologies is
needed. Economising on targeted funding, for example for renewable
energies, makes climate protection more expensive ‑ as scientists of
the Potsdam Institute for Climate Impact Research (PIK) now
calculated for the first time, using a complex computer simulation
that spans the entire 21st century. Without funding, energy
technologies with high cost reduction potentials will hardly stand a
chance, ...
2011-09-19
Using this garment-based patient biomonitoring platform allows us to register a number of the patient's physiological parameters in a non-intrusive manner. "The information gathered by an intelligent t-shirt using e-textile technology is sent, without using wires, to an information management system, which then shows the patient's location and vital signs in real time", explain the UC3M researchers. The system is designed to be used in hospitals and can be divided into two parts: the fixed infrastructure, which would be pre-installed in the hospital, and the mobile units, ...
2011-09-19
For the first time, a major cultural institution is leveraging four Guide by Cell mobile technologies to provide a wide range of interactive choices for the visitor experience.
This summer, San Francisco's Fort Mason Center launched the year-long "SEAT" exhibition featuring over 30 Bay Area artists, each creating their own interpretation of a "seat."
SEAT is the first exhibition in the country to integrate the full Guide by Cell suite of mobile services. The SEAT works, built by local architects, concrete designers, blacksmiths, woodworkers, ...
2011-09-19
In biologically active enzyme substrate compounds, as can be found in medicines, water plays a more decisive role than has been imagined up to now. The surrounding water acts like an "adhesive", in order to keep the substrate at the right place on an enzyme. For this, the dynamism of the water is retarded. Scientists at the RUB under Prof. Dr. Martina Havenith (Physical Chemistry) in close cooperation with the group of Prof. Irit Sagi from the Israeli Weizmann Institute have been able to observe and prove the retardation of the water's dynamism "live" for the first time ...
2011-09-19
Premium knee implants, such as high-flexion knees were created to address specific patient needs and to promote additional function. But whether these higher cost devices provide greater longevity than their standard lower-cost counterparts remains to be seen in the medical literature.
Studies that have evaluated the functional results of premium vs. standard implants have demonstrated similar results between the prostheses.
Since the Zimmer NexGen knee replacement system has been on the market, almost half a million people in the US alone have had Zimmer knee implants. ...
2011-09-19
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary ...
2011-09-19
Research by the University of Liverpool has found that intervention policies that promote healthy eating could cut the death rate for cardiovascular disease (CVD) by up to 50%.
Professor Simon Capewell from the Institute of Psychology, Health and Well-being found that intervention policies which reduce unhealthy eating habits can have a significant effect on levels of CVD at both an individual and population level.
Poor diet is one of the major causes of CVD and small improvements can make a positive and rapid impact on both the individual and the wider population. ...
2011-09-19
The lawsuit against Lawrence Livermore National Lab, as referenced in a 9/11/11 New York Times article, is a reflection of very serious issues confronting the laboratory. 130 former plaintiffs allege they were illegally laid off by LLNS in a flagrant demonstration of age discrimination. Tuesday, September 13, 2011 the lawsuit, which was filed May 2009, was set for trial on February 6, 2012 in the Alameda County Superior Court. The law firm of Gwilliam, Ivary, Chiosso, Cavalli & Brewer, Oakland, California represents the 130 plaintiffs in this consolidated action. The ...
2011-09-19
Researchers from North Carolina State University are proposing a health-based approach to identifying groups at high risk of genocide, in a first-of-its-kind attempt to target international efforts to stop these mass killings before they start.
Genocide, or the willful attempt to exterminate a specific population, is a violation of international law. In recent years, international discussion of genocide has focused in part on finding ways to identify populations at risk in order to prevent a problem before it starts.
Some risk factors have already been identified, such ...
LAST 30 PRESS RELEASES:
[Press-News.org] Queen's pioneers prostate cancer breakthrough
